| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/20/2000 | WO2000022138A1 Genetic factor of s. meliloti usda 1170 containing nodulation efficiency factor |
| 04/20/2000 | WO2000022130A2 Metastatic breast and colon cancer regulated genes |
| 04/20/2000 | WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022125A2 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | WO2000022122A2 Genes, proteins and biallelic markers related to central nervous system disease |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | WO2000021995A1 Treatment of inflammatory disease |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 04/20/2000 | WO2000021978A2 Laminin 5, 13 and 14 and uses thereof |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021551A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | WO2000021504A1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 04/20/2000 | WO2000003687A3 Potassium channel polypeptide and polynucleotide compositions |
| 04/20/2000 | WO2000003021A3 Metabolically engineered microbial cell comprising a modified redox activity |
| 04/20/2000 | WO2000003000A3 Serum-free medium for culturing animal cells |
| 04/20/2000 | WO2000000622A3 Human oxidoreductase proteins |
| 04/20/2000 | WO2000000506A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053078A3 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
| 04/20/2000 | DE19848129A1 New nucleic acid sequence encoding Alcaligenes faecalis nitrilase polypeptide useful for converting racemic nitriles to chiral carboxylic acids |
| 04/20/2000 | DE19848017A1 Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences |
| 04/20/2000 | DE19848016A1 Production of extracellular microbial protein, particularly esterolytic enzymes, in heterologous bacteria transformed with appropriate nucleic acid and secretory apparatus |
| 04/20/2000 | DE19846499A1 Production of microorganisms that overproduce pantothenic acid, useful as vitamin in e.g. foods or medicines, by overexpressing sequences that encode ketopantothenate reductase |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346943A1 Cyclic tetrapeptide compound and use thereof |
| 04/20/2000 | CA2346877A1 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346743A1 Metabolic selection methods |
| 04/20/2000 | CA2346499A1 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |
| 04/20/2000 | CA2346364A1 Method for determining transcription factor activity and its technical uses |
| 04/20/2000 | CA2346259A1 Means and methods for modulating stomata characteristica in plants |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | CA2346008A1 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2345904A1 Nucleic acid molecules encodeing a branching enzyme from bacteria of the genus neisseria as well as methods for the production of .alpha.-1,6-branched .alpha.-1,4-glucans |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2345352A1 Improved method for more efficient electroporation |
| 04/20/2000 | CA2344978A1 Genes, proteins and biallelic markers related to central nervous system disease |
| 04/20/2000 | CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2326675A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994192A2 Transformation cassette for yeast |
| 04/19/2000 | EP0994190A2 DNA conferring L-homoserine resistance to bacteria, and its use |
| 04/19/2000 | EP0994183A1 Functional compositions |
| 04/19/2000 | EP0994182A2 Process for the synchronisation of cell division of at least a population in a culture or and preparation of at least a substance dependent of a cell cyclus by using the population obtained by the synchronised process |
| 04/19/2000 | EP0993469A1 COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| 04/19/2000 | EP0677109B1 Expression system for producing apolipoprotein ai-m |
| 04/19/2000 | EP0667872B1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 04/19/2000 | EP0222835B2 Oral vaccines |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251132A Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 04/19/2000 | CN1251108A Beta-ketoacyl-acp-synthetase II enzyme and gene encoding same |
| 04/18/2000 | US6051755 Modification of plant lipids and seed oils utilizing yeast SLC genes |
| 04/18/2000 | US6051697 Chemokine expressed in eosinophils |
| 04/18/2000 | US6051692 Amino acid sequence; for prevention, treatment and diagnosis of disorders associated with cellular development and differentiation and retinoid metabolism; vision defects; skin disorders; urogenital disorders; addison's disease |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051550 Materials and methods for controlling homopteran pests |
| 04/18/2000 | US6051430 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | US6051420 Method for the decontamination of soil containing solid organic explosives therein |
| 04/18/2000 | US6051419 Genes which influence pichia proteolytic activity, and uses therefor |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051408 Gene and gene structure coding for an aminotransferase, and microorganisms which express this gene |
| 04/18/2000 | US6051407 A dna encoding a protein; regulating the production of cellulose in prokaryotic and eukaryotic cells |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051381 Escherichia host cell containing a fusion protein, a dna binding domain, protein interacting domain, and a reporter gene linked to a promoter; used as a yeast two-hybrid system; interaction cloning, mapping/analyzing protein interactions |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051237 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051219 Method for reducing malodor with Bacillus subtilis Kubota |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | US6051130 Bioreactor for remediation of pollutants with butane utilizing bacteria |
| 04/18/2000 | CA2192184C Extraction of heterologous insoluble proteins from bacteria |
| 04/17/2000 | CA2284849A1 Episomally replicating vector, its preparation and use |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 04/13/2000 | WO2000020601A2 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020597A1 Novel strains of the bacillus subtilis group for food fermentation |
| 04/13/2000 | WO2000020596A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 04/13/2000 | WO2000020595A1 Interleukin-1 homolog |
| 04/13/2000 | WO2000020594A1 Tsg-5: a tnf-inducible gene |